drugset / Trial / NCT03066583

Effectiveness of Trephination With Platelet Rich Plasma or Placebo in a Primary Meniscal Tear Treatment

NCT03066583

Phase 2/3 Completed 72 enrolled Centre of Postgraduate Medical Education
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will compare meniscal healing augmented or without augmentation with platelet rich plasma in primary meniscal tear treatment (prolotherapy). The assessments will include validated, disease specific, patient oriented outcome measures. Results of this study will help ascertain whether platelet rich plasma may improve meniscal healing rates.

Timeline

Start
2016-01
Primary completion
2019-01
Completion
2020-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified

Indications

No indication recorded.